학술논문

Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.
Document Type
journal article
Source
BMC Pediatrics; 7/14/2017, Vol. 17, p1-10, 10p, 1 Diagram, 2 Charts
Subject
RETROLENTAL fibroplasia
PROPRANOLOL
NEOVASCULARIZATION
PEDIATRICS
PEDIATRIC ophthalmology
THERAPEUTICS
ADRENERGIC beta blockers
OPHTHALMIC drugs
CLINICAL trials
COMPARATIVE studies
PREMATURE infants
LONGITUDINAL method
RESEARCH methodology
MEDICAL cooperation
RESEARCH protocols
RESEARCH
CUTANEOUS therapeutics
EVALUATION research
TREATMENT effectiveness
Language
ISSN
14712431
Abstract
Copyright of BMC Pediatrics is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)